RS

Rupam Sarkar

Director Director DIN 02061798
DIN 02061798 First appointment Jun 1991 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jun 1991
Shareholding value •••• Premium profile

About Rupam Sarkar

Data last updated:

Rupam Sarkar was a Director at Stafford Laboratories Private Limited (1999–2010) and Director at Pee Dee Pharma Pvt Ltd (1991–2010). The companies operate in Pharma.

DIN 02061798
Primary Designation Director
Industry Pharma
First Appointment 20 Jun 1991

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 May 19991999₹33.42 Cr (FY 2024)Active
Pee Dee Pharma Pvt Ltd U24232WB1991PTC052082
Director20 Jun 19911991₹80.9 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Stafford Laboratories Private Limited
Pee Dee Pharma Pvt Ltd
Premium access

Shareholding and investment profile for Rupam Sarkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rupam Sarkar

Rupam Sarkar was first appointed on 20 Jun 1991 as Director at Pee Dee Pharma Pvt Ltd. The most recent appointment on record is 17 May 1999 at Stafford Laboratories Private Limited.

Rupam Sarkar held 2 earlier board appointments: Stafford Laboratories Private Limited (Director, 17 May 1999 to 15 Nov 2010); Pee Dee Pharma Pvt Ltd (Director, 20 Jun 1991 to 15 Nov 2010).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available